We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.23T
AUM Growth
+$95.5B
Cap. Flow
+$28B
Cap. Flow %
2.27%
Top 10 Hldgs %
29.78%
Holding
4,685
New
98
Increased
3,266
Reduced
979
Closed
150

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.57B
2
MSFT icon
Microsoft
MSFT
+$1.4B
3
NVDA icon
NVIDIA
NVDA
+$1.36B
4
AMZN icon
Amazon
AMZN
+$1.19B
5
AVGO icon
Broadcom
AVGO
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 31.03%
2 Financials 12.84%
3 Healthcare 11.54%
4 Consumer Discretionary 10.45%
5 Industrials 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVEX icon
3026
Eve Holding
EVEX
$962M
$2.75M ﹤0.01%
850,022
+336,133
+65% +$1.02M
PBFS icon
3027
Pioneer Bancorp
PBFS
$434M
$2.74M ﹤0.01%
250,178
+27,786
+12% +$302K
III icon
3028
Information Services Group
III
$251M
$2.71M ﹤0.01%
820,929
+70,135
+9% +$230K
XENE icon
3029
Xenon Pharmaceuticals
XENE
$6.12B
$2.71M ﹤0.01%
68,809
-120
-0.2% -$4.84K
PRTH icon
3030
Priority Technology Holdings
PRTH
$444M
$2.71M ﹤0.01%
396,335
+21,598
+6% +$121K
KLTR icon
3031
Kaltura
KLTR
$267M
$2.71M ﹤0.01%
1,990,252
+124,415
+7% +$153K
TIL icon
3032
Instil Bio
TIL
$50.3M
$2.7M ﹤0.01%
40,131
+3,738
+10% +$88K
PSNL icon
3033
Personalis
PSNL
$1.51B
$2.68M ﹤0.01%
498,470
+83,068
+20% +$342K
PAMT
3034
PAMT Corp
PAMT
$297M
$2.68M ﹤0.01%
144,862
+966
+0.7% +$17.6K
TTEC icon
3035
TTEC Holdings
TTEC
$124M
$2.68M ﹤0.01%
455,750
-5,687
-1% -$31K
SMTI icon
3036
Sanara MedTech
SMTI
$313M
$2.67M ﹤0.01%
88,271
+3,755
+4% +$117K
CHRS icon
3037
Coherus Oncology
CHRS
$196M
$2.67M ﹤0.01%
2,565,145
+182,914
+8% +$251K
VSTM icon
3038
Verastem
VSTM
$610M
$2.66M ﹤0.01%
890,599
+359,060
+68% +$974K
NODK icon
3039
NI Holdings
NODK
$320M
$2.65M ﹤0.01%
169,290
+3,092
+2% +$47K
AGEN
3040
Agenus
AGEN
$290M
$2.65M ﹤0.01%
483,059
+32,016
+7% +$240K
MLCO icon
3041
Melco Resorts & Entertainment
MLCO
$2.14B
$2.62M ﹤0.01%
336,679
-20,329
-6% -$120K
JOYY
3042
JOYY Inc
JOYY
$3.75B
$2.61M ﹤0.01%
72,152
+877
+1% +$30.2K
MRUS
3043
DELISTED
Merus
MRUS
$2.6M ﹤0.01%
52,096
-90
-0.2% -$4.7K
CVRX icon
3044
CVRx
CVRX
$63.4M
$2.6M ﹤0.01%
295,124
+6,443
+2% +$58.6K
ARDT
3045
Ardent Health
ARDT
$1.66B
$2.58M ﹤0.01%
+140,436
New +$2.48M
PEBK icon
3046
Peoples Bancorp of North Carolina
PEBK
$229M
$2.58M ﹤0.01%
101,583
-168
-0.2% -$4.84K
ODD icon
3047
ODDITY Tech
ODD
$651M
$2.57M ﹤0.01%
63,625
+750
+1% +$28.9K
BILI icon
3048
Bilibili
BILI
$7.84B
$2.56M ﹤0.01%
109,420
-190
-0.2% -$2.95K
RUSHB icon
3049
Rush Enterprises Class B
RUSHB
$6.14B
$2.55M ﹤0.01%
53,194
+7,602
+17% +$343K
SKIN icon
3050
SkinHealth Systems
SKIN
$85.7M
$2.53M ﹤0.01%
1,756,667
-38,838
-2% -$63.6K

Similar funds

Geode Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
  • Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
  • Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
  • Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
  • Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
  • Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
  • Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.

Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.